Hartmut Lüss

Title: Hartmut Lüss: Innovator in Heart Failure Treatment

Introduction

Hartmut Lüss is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of heart failure. His innovative approach has led to the development of a unique patent that addresses a critical health issue.

Latest Patents

Hartmut Lüss holds a patent for the "Use of natriuretic peptide for treating heart failure." This invention relates to the use of a natriuretic peptide, such as urodilatin, for treating patients suffering from heart failure, including acute decompensated heart failure. The patent outlines a method where a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously for a period ranging from at least 24 hours to up to 120 hours, with a preference for at least 48 hours. This innovative treatment method has the potential to improve patient outcomes significantly.

Career Highlights

Throughout his career, Hartmut Lüss has worked with various companies, including Cardiopep Pharma GmbH and Cardiorentis AG. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to advancements in heart failure treatments.

Collaborations

Some of Hartmut Lüss's notable coworkers include Veselin Mitrovic and Wolf-Georg Forssmann. Their collaborative efforts have further enhanced the research and development of effective treatments for heart conditions.

Conclusion

Hartmut Lüss is a distinguished inventor whose work in the medical field has led to innovative solutions for heart failure treatment. His patent on the use of natriuretic peptides represents a significant advancement in patient care.